Clinical Trial

Clinical Research on the Use of Immune Checkpoint Inhibitors Combined With Chidamide for the Functional Cure of AIDS

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the efficacy and safety of immune checkpoint inhibitors combined with chidamide as an "activate and kill" strategy to extend viral rebound time, reduce the HIV reservoir, and achieve functional cure.
Trial Details
NCT Number NCT06902038
Lead Sponsor Jun Chen, MD
Conditions HIV-1 Infection
Enrollment 33 participants
Start Date 2025-03-22
Primary Completion 2025-12-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-30